Catinazzo Thomas

Chief Financial Officer | Senior Vice President, Finance

1 company

Strong

Trades Analyzed

12M Win Rate

75.0%

Avg 3M Return

+5.5%

Avg 12M Return

+15.1%

Catinazzo Thomas is a Chief Financial Officer at Relay Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $2.8M based on current market prices.

Holdings by Company

RLAYApr 9, 2026

Current Shares213.9K

Value$2.80M

Net Activity-362,908

Bought: 0Sold: 362.9K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 27, 2024	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	6,457	$7.46	$48,183.97	-1.0%	-40.3%	-30.7%
Jul 29, 2024	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	10,780	$8.56	$92,316.48	-1.6%	-26.6%	-55.9%
Jun 27, 2024	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	9,373	$6.24	$58,493.42	-1.4%	+12.1%	-47.6%
Apr 29, 2024	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	1,695	$6.38	$10,814.10	-0.5%	+24.7%	-53.0%
Mar 27, 2024	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	348	$7.70	$2,679.60	-0.1%	-17.4%	-63.4%
Jan 29, 2024	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	2,005	$9.64	$19,328.20	-0.6%	-33.7%	-53.5%
Dec 27, 2023	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	294	$11.51	$3,383.94	-0.2%	-33.6%	-61.0%
Oct 30, 2023	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	1,697	$6.03	$10,232.91	-1.2%	+59.6%	-5.3%
Sep 27, 2023	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	294	$8.38	$2,463.72	-0.2%	+39.0%	-10.4%
Jul 28, 2023	RLAY Relay Therapeutics, Inc.	Chief Financial Officer	Sell	1,693	$11.80	$19,977.40	-1.1%	-48.2%	-26.9%